Randomised controlled trial of injection of botulinum toxin into the internal anal sphincter versus control in treatment of chronic idiopathic constipation in children

ISRCTN ISRCTN24521269
DOI https://doi.org/10.1186/ISRCTN24521269
Secondary identifying numbers N0013146059
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
16/04/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Dr Graham Clayden
Scientific

Sherman Education Centre
F04 Thomas Guy House
Guy's Hospital
St Thomas Street
London
SE1 9RT
United Kingdom

Phone +44 (0)20 7188 4593
Email Graham.clayden@kcl.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleRandomised controlled trial of injection of botulinum toxin into the internal anal sphincter versus control in treatment of chronic idiopathic constipation in children
Study hypothesisTo investigate the role of needle-free injection of botulinum toxin into external anal sphincter versus injection of the toxin into internal anal sphincter using ordinary needle versus control
Ethics approval(s)Not provided at time of registration
ConditionDigestive System: Constipation
InterventionA randomized-controlled trial of botulinum toxin injection versus control in children with chronic idiopathic constipation. The children are randomly allocated by surgeons into two treatment groups after anorectal manometry under ketamine anaesthetic:
Group 1 = injection of botulinum toxin into the internal anal sphincter
Group 2 = the control group who would have the benefits from the hospital admission to have anorectal studies, manual evacuation of stool if necessary, intensification of laxative treatment and toilet training but no botulinum toxin treatment.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Botulinum toxin
Primary outcome measureImprovement in patients symptom severity score determined by parents completed questionnaire.
Secondary outcome measuresNot provided at time of registration
Overall study start date08/10/2003
Overall study end date01/05/2006

Eligibility

Participant type(s)Patient
Age groupChild
SexBoth
Target number of participants80
Participant inclusion criteria80 children with idiopathic chronic constipation referred for anorectal manometry and inpatient bowel management programme.
Participant exclusion criteria1. Patients younger than 3 years old or older than 16 years
2. Severe learning difficulty
3. Evidence of Hirschsprungs disease on anorectal manometry
4. Previous anal surgery
Recruitment start date08/10/2003
Recruitment end date01/05/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Guy's Hospital
London
SE1 9RT
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Guy's and St. Thomas' NHS Foundation Trust (UK) Own account NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

16/04/2018: No publications found, study status unverified.
10/03/2016: No publications found, verifying study status with principal investigator